Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapy

Collin K. Chin; Sara Hall; Celia Green; Guy Van Hazel; Dominic Spagnolo; Chan Yoon Cheah

doi:10.1016/j.ejca.2019.04.026

Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapy

Collin K. Chin, Sara Hall, Celia Green, Guy Van Hazel, Dominic Spagnolo, Chan Yoon Cheah

Pathology & Laboratory Medicine

Research output: Contribution to journal › Letter › peer-review

11 Citations (Scopus)

Original language	English
Pages (from-to)	84-87
Number of pages	4
Journal	European Journal of Cancer
Volume	115
DOIs	https://doi.org/10.1016/j.ejca.2019.04.026
Publication status	Published - 1 Jul 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2019.04.026

Cite this

@article{6d88ed1a97c6415aad9944d5f5a27dbf,

title = "Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapy",

keywords = "Aged, Antineoplastic Agents, Immunological/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Female, Humans, Ipilimumab/administration & dosage, Lymphohistiocytosis, Hemophagocytic/chemically induced, Melanoma/drug therapy, Nivolumab/administration & dosage, Skin Neoplasms/drug therapy, Steroids/therapeutic use, Treatment Outcome",

author = "Chin, {Collin K.} and Sara Hall and Celia Green and {Van Hazel}, Guy and Dominic Spagnolo and Cheah, {Chan Yoon}",

year = "2019",

month = jul,

day = "1",

doi = "10.1016/j.ejca.2019.04.026",

language = "English",

volume = "115",

pages = "84--87",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier",

}

TY - JOUR

T1 - Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapy

AU - Chin, Collin K.

AU - Hall, Sara

AU - Green, Celia

AU - Van Hazel, Guy

AU - Spagnolo, Dominic

AU - Cheah, Chan Yoon

PY - 2019/7/1

Y1 - 2019/7/1

KW - Aged

KW - Antineoplastic Agents, Immunological/administration & dosage

KW - Antineoplastic Combined Chemotherapy Protocols/administration & dosage

KW - Female

KW - Humans

KW - Ipilimumab/administration & dosage

KW - Lymphohistiocytosis, Hemophagocytic/chemically induced

KW - Melanoma/drug therapy

KW - Nivolumab/administration & dosage

KW - Skin Neoplasms/drug therapy

KW - Steroids/therapeutic use

KW - Treatment Outcome

UR - http://www.scopus.com/inward/record.url?scp=85065904508&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2019.04.026

DO - 10.1016/j.ejca.2019.04.026

M3 - Letter

C2 - 31129384

AN - SCOPUS:85065904508

SN - 0959-8049

VL - 115

SP - 84

EP - 87

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapy

UN SDGs

Access to Document

Other files and links

Cite this